Purpose or Objective: The programmed death ligand 1 (PD-L1) plays a key role in tumour progression and metastasis of pancreatic ductal adenocarcinoma (PDAC) . Although recent preclinical studies have explored the radiosensitising potential of PD-1/PD-L1 inhibitors, the effect of PD-L1 blockade on the response of PDAC to radiotherapy remains unexplored.
Material and Methods: Herein, we investigated the influence of an anti-PD-L1 mAb on the tumour response to single dose and fractionated radiotherapy, and chemotherapy with gemcitabine and capecitabine.
Results: In-vitro, radiation and chemotherapy resulted in PD-L1 upregulation in both human (PSN-1) and murine (KPCderived, Pan02) PDAC cells, although variability was observed. Exposure to conditioned media from pre-treated cells did not alter PD-L1 expression. In-vivo, PD-L1 was also upregulated in the tumour microenvironment after radiation and chemotherapy in the KPC-derived and Pan02 syngeneic mouse models. Similarly, chemotherapy induced PD-L1 upregulation in the KPC (Pdx1Cre, KRASG12D/+, P53R172H/+), a genetically-engineered mouse model of pancreatic cancer. In-vitro, PD-L1 blockade failed to radio-or chemosensitise PDAC cells. The anti-PD-L1 mAb significantly improved tumour response after irradiation in the KPC and Pan02 syngeneic mouse models. This effect was mediated by a cytotoxic T cell-dependent mechanism, whereas blockade of CD8+ cells attenuated the radiosensitising potential of anti-PD-L1. The effect of scheduling of anti-PD-L1 mAb with radiotherapy (concomitant vs sequential) was also investigated. Finally, we assessed the intratumoural and systemic expression of several immune markers (CD45+: CD8, CD4, CD19, NK1.1, CD11b Gr1, Ly6G, CXCR2, FOXP3, IFN-γ) after the different treatments.
Conclusion:
Altogether, our findings support PD-L1 inhibition in combination with radiation as a promising approach in the treatment of PDAC. Purpose or Objective: In this work, the design, fabrication, and operation of a small-scale graphite calorimeter probe (GPC) developed for use as a practical clinical dosimeter, is described. Similar in size and shape to a Farmer-type cylindrical ionization chamber, the GPC represents the first translation of calorimetry from the primary standards dosimetry laboratory to the radiotherapy clinic. Providing a measure of absolute dose, its purpose is to help meet the clinical need for accurate reference dosimetry in nonstandard fields without the need for calibration.
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Material and Methods:
Based on a numerically-optimized design obtained in previous work, a functioning prototype capable of two independent modes of operation (constantpower & constant-temperature) was constructed in-house. In constant-power mode, the radiation-induced temperature rise, ΔT, is measured in the sensitive volume (i.e. the core) while the outermost portion of the device is thermally stabilized by a software-based temperature controller. In constant-temperature mode, the entire device is subject to active thermal control and the quantity of interest is the electrical power, ΔP, necessary to maintain a stable temperature while irradiated. Absorbed dose to water measurements were performed in a water phantom, under standard conditions, using both GPC operation modes in a 6 MV photon beam and subsequently compared to dose to water measurements derived using a reference-class ionization chamber (Exradin A12). Linearity, dose rate, and field size dependence were evaluated by varying the irradiation period, the linac repetition rate, and primary collimating jaw settings, respectively.
Results: Compared to the chamber-derived dose to water of 0.765 cGy/MU, the average GPC-measured doses were 0.765 ± 0.005 (n = 25) and 0.769 ± 0.005 (n = 32) cGy/MU for the constant-power and constant-temperature modes, respectively. The linearity of the detector response was characterized by an adjusted R² value of 0.9996 (n = 40), and no statistically-significant dose rate dependence for rates greater than 1.8 Gy/min was observed. For lower dose rates, an over response of 1.7 % was attributed to the resolution of S134 ESTRO 35 2016 _____________________________________________________________________________________________________ the current-driven temperature controller. No field size dependence was observed down to 2 x 2 cm².
Conclusion:
This work demonstrates the feasibility of using an ion chamber-sized calorimeter as a practical means of measuring absolute dose to water in the radiotherapy clinic. The potential introduction of calorimetry into the clinical setting is significant as this fundamental technique has formed the basis of absorbed dose standards in many countries for decades. Considered as the most direct means of measuring dose, a "calorimeter for the people" could play an important role in solving the major challenges of contemporary dosimetry. In particular, investigations into the use of the GPC for MR-linac dosimetry are currently underway. Purpose or Objective: Build-up material is commonly used in electron beam radiation therapy to overcome the skin sparing effect and to homogenise the dose distribution in case of irregular skin surfaces. Often, an individualised bolus is necessary. This process is complex and highly labourintensive, while adaptation of the bolus is time consuming. We implemented a new clinical workflow in which the bolus is designed on the CT scan in the treatment planning system (TPS). Subsequently a cast with the bolus shape is 3D-printed and filled with silicone rubber to create the bolus itself [1].
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Material and Methods:
In the new workflow ( figure 1) , a patient-specific bolus is designed in the TPS. A 2 mm expansion is used to create a cast around the bolus. Subsequently, this cast is smoothed to remove CT scan resolution effects. After conversion to a stereolithography file, the cast is printed in polylactic acid (PLA) with a filament printer and filled with silicone rubber. After removal of the PLA cast, the bolus is ready for clinical use. Before clinical implementation we performed a planning study with 11 patients to evaluate the difference in tumour coverage with a 3D-print bolus in comparison to the clinically delivered plan with a manually created bolus. During clinical implementation of the 3D-print workflow, for 7 patients a second CT-scan with the 3D-print bolus in position was made to assess its geometrical accuracy and the resulting dose distribution.
Results:
The planning study showed at least equal coverage of GTV and CTV: V95% of the GTV was on average 97% (3Dprint) vs 84% (conventional). V85% of the CTV was on average 97% (3D-print) vs 88% (conventional). Geometric comparison of the 3D-print bolus to the originally contoured bolus showed a high similarity (mean dice similarity coefficient of 0.87 (range 0.81 to 0.95). Comparison of the dose distributions at the planning CT scan to dose distributions at the second CT scan with the 3D print bolus in position showed only small differences (median difference in V95% GTV and V85% CTV of 0% (interquartile range: -12% to 0%) and -1.6% (interquartile range: -3.8 to 0.5%), respectively). Time efficiency of the 3D-print workflow is likely to increase in comparison to the conventional workflow, with one less patient visit, and up to 3 hours less mould room time.
Conclusion:
The implemented workflow is feasible, patient friendly, safe, and results in high quality dose distributions. This new technique increases time efficiency and logistically aligns electron with photon external beam treatments. Residency is a unique period in a professional life where the main objective is to learn. Residency is full of research and educational opportunities for young radiation oncologists to gain know-how and expertise in clinical practice, patient care, fundamental, translational and/or clinical research and innovative technologies in the various aspects of our specialty. Through local, national and international programs, trainees gain valuable clinical and research experience and skills during and rapidly get the opportunity to disseminate information and update colleagues in their home institution. Playing a proactive role in the training will not only give access to the best training opportunities but will motivate as well supervisors in supporting trainee's career development.
In a competitive world with limited resources, building up good curriculum vitae with a number of publications and presentations is a major advantage that should be
